(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BIOLINX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BIOLINX

ST13

US500000077019801

Class

10

Filing

77019801

Registration

3606407

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

44

Latest update

11/22/2019

Trademark type

Word

Nice classes

10

Filing date

10/12/2006

Registration date

04/14/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/22/2019

Last transaction

11/22/2019

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/31/2008

First use in commerce

12/31/2008

Drawing code

4

Owner type

03

Owner location

Santa Rosa, CA

Examiner

MARCY, AMY

Law office

L90

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Medtronic Vascular, Inc.

Representatives

Thomas M Johnston MEDTRONIC, INC.

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

polymeric coating for use as a permanent component of a drug eluting stent

Publications

History of USPTO decisions and trademark events.

44 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

11/22/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

11/22/2019

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/22/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/22/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

10/15/2019

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

04/14/2018

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/13/2015

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/13/2015

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/13/2015

E815

TEAS SECTION 8 & 15 RECEIVED

03/31/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/31/2015

R.PR

REGISTERED-PRINCIPAL REGISTER

04/14/2009

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

03/09/2009

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/06/2009

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/11/2009

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/10/2009

IUAF

USE AMENDMENT FILED

01/26/2009

EISU

TEAS STATEMENT OF USE RECEIVED

01/26/2009

EX2G

SOU EXTENSION 2 GRANTED

08/01/2008

EXT2

SOU EXTENSION 2 FILED

08/01/2008

EEXT

SOU TEAS EXTENSION RECEIVED

08/01/2008

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/01/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/01/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/14/2008

EX1G

SOU EXTENSION 1 GRANTED

02/07/2008

EXT1

SOU EXTENSION 1 FILED

02/07/2008

EEXT

SOU TEAS EXTENSION RECEIVED

02/07/2008

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/07/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/07/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/30/2008

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

08/14/2007

PUBO

PUBLISHED FOR OPPOSITION

05/22/2007

NPUB

NOTICE OF PUBLICATION

05/02/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/27/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/27/2007

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/26/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/26/2007

ALIE

ASSIGNED TO LIE

03/26/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/19/2007

GNRT

NON-FINAL ACTION E-MAILED

12/18/2006

CNRT

NON-FINAL ACTION WRITTEN

12/18/2006

DOCK

ASSIGNED TO EXAMINER

12/11/2006

MPMK

NOTICE OF PSEUDO MARK MAILED

10/17/2006

NWAP

NEW APPLICATION ENTERED

10/16/2006

Continuous trademark protection

Get notified about every new filing that threatens BIOLINX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.